Position
Creative Planning in 10x Genomics, Inc.
Back to the book · All holders of TXG
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $288.9K$16.31 → $21.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 58.7K | $957.7K | — | — | — | 0.0% |
| Q1 2026 | 91.3K | $1.94M | $21.23 | $288.9K | $691.9K | 0.0% |